{"product_id":"ww-bcg-matrix","title":"WW International Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock Strategic Clarity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eWW International’s BCG Matrix snapshot shows a company balancing branded weight-management programs and digital subscriptions—some offerings acting as Stars in growing health-tech markets while legacy products trend toward Cash Cows or Question Marks amid shifting consumer habits; targeted investment and portfolio pruning could sharpen returns. This preview scratches the surface—purchase the full BCG Matrix to get quadrant-by-quadrant placement, data-driven recommendations, and ready-to-use Word and Excel deliverables to guide strategic and investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWW Clinic Clinical Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe WW Clinic Clinical Solutions is WW International’s highest-growth star, integrating GLP-1 medications and behavioral support and driving a shift into clinical obesity care.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the unit captured an estimated 12–15% share of the US clinical obesity management market and contributed roughly $220–260M in run-rate revenue, leveraging WeightWatchers’ trusted brand.\u003c\/p\u003e\n\u003cp\u003eIt requires heavy investment in medical staff and telehealth platforms—capex and operating spend rose ~40% in 2024–25—but remains the portfolio leader.\u003c\/p\u003e\n\u003cp\u003eThis unit is essential to transition WW from a diet company to a full healthcare provider, underpinning long-term margin and ARPU expansion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eB2B Corporate Wellness Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWW International (WeightWatchers) has rapidly grown its B2B employer-sponsored segment, signing enterprise deals covering over 1.2 million lives by 2024 and driving corporate revenue that rose ~18% YoY in FY2024.\u003c\/p\u003e\n\u003cp\u003eAs employers face rising chronic-disease costs—US employer health spend up 5.2% in 2024—WW’s clinical + digital platform is a high-growth cash cow, favored for large-scale deployments.\u003c\/p\u003e\n\u003cp\u003eTo keep leadership, WW needs continued investment in sales (added 40% more enterprise reps in 2023) and enhanced enterprise reporting to meet ROI and compliance demands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGLP-1 Companion Behavioral Program\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe GLP-1 Companion Behavioral Program is a digital subscription for patients on external weight-loss drugs, targeting the fast-growing GLP-1 user base—estimated 13.5M U.S. adults as of 2024—with content on muscle preservation, protein intake, and habit formation not covered by medications.\u003c\/p\u003e\n\u003cp\u003eLeveraging WW International’s behavioral science lead and 50%+ market share in paid weight-management coaching, the program has scaled rapidly and qualifies as a Star in the BCG matrix, driving higher ARPU and retention versus standard plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Telehealth Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Integrated Telehealth Platform is a high-growth, proprietary tech asset linking members with clinicians and registered dietitians, driving WW International’s clinical expansion and recurring revenue.\u003c\/p\u003e\n\u003cp\u003eBy late 2025 the app ingests biometric data and EHRs (electronic health records), improving outcomes and creating a durable moat rivals find hard to replicate.\u003c\/p\u003e\n\u003cp\u003eIt needs ongoing capex for cybersecurity and UX; WW reported ~ $120m in tech and R\u0026amp;D spend in FY2024, underscoring investment intensity.\u003c\/p\u003e\n\u003cp\u003eThe platform is the scalable technical backbone for global rollout and telehealth monetization.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-growth proprietary stack\u003c\/li\u003e\n\u003cli\u003eBiometric + EHR integration (late 2025)\u003c\/li\u003e\n\u003cli\u003eOngoing capex and security spend (~$120m FY2024)\u003c\/li\u003e\n\u003cli\u003eEnables global clinical scale\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Clinical Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eWW launched clinical weight-management services across Germany, UK, Spain, Canada and Australia in 2025, targeting markets where regulated, medical-led care grew 22–30% YoY and reimbursement pilots expanded in Q1–Q3 2025.\u003c\/p\u003e\n\u003cp\u003eThese expansions drive higher CAC and regulatory spend—estimated €18–22M in 2025 for compliance and local medical staffing—but revenue growth outpaced WW digital-only sales by ~35% in early rollout markets.\u003c\/p\u003e\n\u003cp\u003eCapturing these regions could make WW a global medical-wellness leader, with projected clinical segment ARR of $120–160M by end-2026 if uptake follows current trends.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLaunched in 5 markets in 2025\u003c\/li\u003e\n\u003cli\u003eLocal demand growth 22–30% YoY\u003c\/li\u003e\n\u003cli\u003eRegulatory\/staffing spend €18–22M (2025)\u003c\/li\u003e\n\u003cli\u003eRevenue +35% vs digital-only in rollouts\u003c\/li\u003e\n\u003cli\u003eProjected clinical ARR $120–160M by 2026\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWW Clinical Suite: Market-Leading GLP-1 \u0026amp; Telehealth — $220–260M Run-Rate, 12–15% US Share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWW’s clinical suite (Clinic Solutions, GLP-1 Companion, Telehealth) are Stars: high growth, market-leading tech and behavioral assets—~12–15% US clinical share, $220–260M run-rate (end-2025), tech\/R\u0026amp;D ~$120M FY2024, enterprise reach 1.2M lives; international rollouts add €18–22M compliance spend (2025) with projected clinical ARR $120–160M by end-2026.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024–25)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS clinical share\u003c\/td\u003e\n\u003ctd\u003e12–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRun-rate revenue\u003c\/td\u003e\n\u003ctd\u003e$220–260M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTech\/R\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnterprise lives\u003c\/td\u003e\n\u003ctd\u003e1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl compliance spend\u003c\/td\u003e\n\u003ctd\u003e€18–22M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected ARR (2026)\u003c\/td\u003e\n\u003ctd\u003e$120–160M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review of WW International’s portfolio with quadrant-specific strategies, risks, and investment recommendations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page WW International BCG Matrix placing each segment in a quadrant for swift strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCore Digital Subscription Plans\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe standard points-based digital app is WW International’s primary steady cash flow, with 2024 digital subscription revenue around $500M, serving a mature market with \u0026gt;3.5M active subscribers and high brand recognition.\u003c\/p\u003e\n\u003cp\u003eTechnology is stable, so incremental investment is low versus clinical programs; subscription gross margins exceed 60%, and profits fund R\u0026amp;D for higher-growth initiatives like digital therapeutics and personalized coaching.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Product Licensing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWW International earns roughly $120–140 million annually from consumer product licensing, placing the WW logo on supermarket items and generating high-margin, low-overhead cash.\u003c\/p\u003e\n\u003cp\u003eBranded diet food is a mature, low-growth market, yet WW’s leading share keeps licensing revenue steady, supporting debt service and preserving liquidity on the balance sheet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNorth American Digital Market Share\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIn the United States and Canada, WW (WeightWatchers International, Inc.) holds roughly 40–45% share of the digital weight-management market as of 2025, driven by 60+ years of brand history and peer-reviewed science that lower retention marketing spend by ~15% versus newer apps.\u003c\/p\u003e\n\u003cp\u003eThis mature digital cash cow generates net positive free cash flow—WW reported $150 million operating cash flow in FY2024—funding R\u0026amp;D and clinical pivots while cushioning the company against economic swings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Membership Renewals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eLegacy Membership Renewals generate steady recurring revenue for WW International, with legacy members accounting for roughly 40–50% of subscription revenue as of FY2024 and showing annual churn under 8%, making them highly efficient cash cows.\u003c\/p\u003e\n\u003cp\u003eThese long-term members need minimal promotion because they are embedded in WW’s digital and in-person ecosystem, so margins on renewal revenue exceed newer acquisition cohorts and fund high-growth Question Mark pilots.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLegacy members ≈ 40–50% of subscription revenue (FY2024)\u003c\/li\u003e\n\u003cli\u003eAnnual churn \u0026lt; 8% for long-tenure cohort\u003c\/li\u003e\n\u003cli\u003eHigh margin renewals fund Question Mark initiatives\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWW Branded Retail Merchandise\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eWW Branded Retail Merchandise—kitchen tools, scales, snacks—remains a steady cash cow, generating reliable revenue via WW’s e-commerce channels and third-party retailers; in 2024 retail merchandise contributed roughly $120m in revenue, supporting margins around 18–22% due to scale and efficient manufacturing.\u003c\/p\u003e\n\u003cp\u003eNot high-growth but stable within the wellness niche, this segment fuels corporate liquidity, covering a meaningful share of global admin costs and freeing capital for digital and program investments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 retail revenue ≈ $120m\u003c\/li\u003e\n\u003cli\u003eGross margins ~18–22%\u003c\/li\u003e\n\u003cli\u003eStable demand in wellness niche\u003c\/li\u003e\n\u003cli\u003eSupports admin and investment cash needs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWW’s $150M+ FY24 cash engine: $500M digital subs, high‑margin licensing \u0026amp; retail\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWW’s cash cows: digital subscriptions (~$500M 2024), legacy renewals (40–50% of subs, \u0026lt;8% churn), consumer licensing ($120–140M), and retail merchandise (~$120M, 18–22% GM) generate \u0026gt;$150M operating cash flow in FY2024, funding R\u0026amp;D and clinical pivots.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 rev\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital subs\u003c\/td\u003e\n\u003ctd\u003e$500M\u003c\/td\u003e\n\u003ctd\u003e3.5M users\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicensing\u003c\/td\u003e\n\u003ctd\u003e$120–140M\u003c\/td\u003e\n\u003ctd\u003eHigh margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003ctd\u003eGM 18–22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eWW International BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe preview you're viewing is the exact BCG Matrix file you'll receive after purchase—fully formatted, market-informed, and free of watermarks or demo content; immediately downloadable and ready for editing, printing, or presenting to stakeholders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748119392633,"sku":"ww-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/ww-bcg-matrix.png?v=1772205002","url":"https:\/\/matrixbcg.com\/products\/ww-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}